Thonburi Healthcare Group Public Company Limited (THG) announced in reference is made to the letter of the Office of the Securities and Exchange Commission, dated 4 August 2021 issued pursuant to Section 58(1) of the Securities and Exchange Act B. E. 2535 (1992) requesting the management of the company to provide a statement of clarification and submit the relevant documents and evidence to the SEC Office and disclose such clarification via the information disclosure system of the Stock Exchange of Thailand within 7 days from the date of such letter.
THG has informed that the company has received such a letter from the SEC Office and will submit the statement of clarification within the required period of time. THG would like to preliminarily provide a summary of information as follows:
1) The company “did not mention the entry into or the entering into an agreement with the Ministry of Defense” as earlier reported. It is a fact that the company has entered into a memorandum of understanding with a governmental agency. THG will disclose such an attached document to the SEC office under the statement of clarification.
2) The company did not use its cash, loan facility or asset as deposit and deposit penalty for the vaccine.
3) In respect of the 20 million doses vaccine that has been in discussion with the distributor, a purchase order of such vaccine has not been issued by the responsible governmental agency. THG continues to pursue the importation of mRNA vaccines and other vaccines. The number of doses and the duration of vaccine importation cannot be specified due to situation change all the time.
Even though “the company is not responsible for procurement of Covid-19 vaccines according to the governmental regulations.” THG only intends to act in its role as “private sector and citizen” who do not neglect the COVID-19 pandemic in order for the country to pass through this crisis as soon as possible.